XML 27 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement and Amendment of Previously Reported Financial Information Summary of Correction of Errors, Cash Flow (Details) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2012
Dec. 31, 2012
OPERATING ACTIVITIES:    
Net income (loss) $ (54,600,000)  
Net realized investment (gains) losses 16,500,000  
Policy acquisition costs deferred (43,500,000)  
Policy acquisition cost amortization 68,300,000  
Interest credited 122,300,000  
Equity in earnings of limited partnerships and other investments (100,000)  
Change in:    
Accrued investment income (5,500,000)  
Deferred income taxes, net (5,700,000)  
Receivables 32,600,000  
Policy liabilities and accruals (171,300,000)  
Due to/from affiliate 10,900,000  
Other operating activities, net (14,200,000)  
Cash provided by (used for) operating activities (76,600,000)  
Purchases of:    
Available-for-sale debt securities (524,000,000)  
Derivative instruments (29,200,000)  
Fair value investments (2,900,000)  
Sales, repayments and maturities of:    
Proceeds from sales   160,000,000
Derivative instruments 12,100,000  
Fair value investments 3,000,000  
Contributions to limited partnerships (900,000)  
Distributions from limited partnerships 200,000  
Policy loans, net 2,400,000  
Other investing activities, net (400,000)  
Cash provided by (used for) investing activities (312,900,000)  
FINANCING ACTIVITIES:    
Policyholder deposit fund deposits 540,500,000  
Policyholder deposit fund withdrawals (265,400,000)  
Net transfers to/from separate accounts 142,000,000  
Cash provided by (used for) financing activities 417,100,000  
Change in cash and cash equivalents 27,600,000  
Cash and cash equivalents, beginning of year 49,500,000 49,500,000
Cash and cash equivalents, end of year 77,100,000 83,100,000
Supplemental Disclosure of Cash Flow Information    
Income taxes paid (refunded) 22,200,000.0  
Non-Cash Transactions During the Year    
Investment exchanges 14,000,000  
Corrections of Errors
   
OPERATING ACTIVITIES:    
Net income (loss) (51,500,000)  
Net realized investment (gains) losses 1,700,000  
Policy acquisition costs deferred 9,400,000  
Policy acquisition cost amortization 12,600,000  
Interest credited 122,300,000  
Equity in earnings of limited partnerships and other investments 0  
Change in:    
Accrued investment income (1,600,000)  
Deferred income taxes, net 11,900,000  
Receivables 4,600,000  
Policy liabilities and accruals (203,300,000)  
Due to/from affiliate 10,900,000  
Other operating activities, net (10,700,000)  
Cash provided by (used for) operating activities (93,700,000)  
Purchases of:    
Available-for-sale debt securities 17,900,000  
Derivative instruments 0  
Fair value investments (2,900,000)  
Other investments 900,000  
Sales, repayments and maturities of:    
Proceeds from sales (17,200,000)  
Derivative instruments 0  
Fair value investments 3,000,000  
Other investments (200,000)  
Contributions to limited partnerships (900,000)  
Distributions from limited partnerships 200,000  
Policy loans, net 1,000,000  
Other investing activities, net (400,000)  
Cash provided by (used for) investing activities 1,400,000  
FINANCING ACTIVITIES:    
Policyholder deposit fund deposits 130,300,000  
Policyholder deposit fund withdrawals (182,600,000)  
Net transfers to/from separate accounts 142,000,000  
Cash provided by (used for) financing activities 89,700,000  
Change in cash and cash equivalents (2,600,000)  
Cash and cash equivalents, beginning of year (18,000,000) (18,000,000)
Cash and cash equivalents, end of year (20,600,000)  
Supplemental Disclosure of Cash Flow Information    
Income taxes paid (refunded) 22,200,000  
Non-Cash Transactions During the Year    
Investment exchanges 14,000,000  
As previously reported
   
OPERATING ACTIVITIES:    
Net income (loss) (3,100,000)  
Net realized investment (gains) losses 14,800,000  
Policy acquisition costs deferred (52,900,000)  
Policy acquisition cost amortization 55,700,000  
Interest credited 0  
Equity in earnings of limited partnerships and other investments (100,000)  
Change in:    
Accrued investment income (3,900,000)  
Deferred income taxes, net (17,600,000)  
Receivables (4,300,000)  
Policy liabilities and accruals 32,000,000  
Due to/from affiliate 0  
Other operating activities, net (3,500,000)  
Cash provided by (used for) operating activities 17,100,000  
Purchases of:    
Available-for-sale debt securities (601,900,000)  
Derivative instruments (29,200,000)  
Fair value investments 0  
Other investments (900,000)  
Sales, repayments and maturities of:    
Proceeds from sales 304,000,000  
Derivative instruments 12,100,000  
Fair value investments 0  
Other investments 200,000  
Contributions to limited partnerships 0  
Distributions from limited partnerships 0  
Policy loans, net 1,400,000  
Other investing activities, net 0  
Cash provided by (used for) investing activities (314,300,000)  
FINANCING ACTIVITIES:    
Policyholder deposit fund deposits 410,200,000  
Policyholder deposit fund withdrawals (82,800,000)  
Net transfers to/from separate accounts 0  
Cash provided by (used for) financing activities 327,400,000  
Change in cash and cash equivalents 30,200,000  
Cash and cash equivalents, beginning of year 67,500,000 67,500,000
Cash and cash equivalents, end of year 97,700,000  
Supplemental Disclosure of Cash Flow Information    
Income taxes paid (refunded) 0  
Non-Cash Transactions During the Year    
Investment exchanges 0  
As restated and amended
   
OPERATING ACTIVITIES:    
Net income (loss) (54,600,000)  
Net realized investment (gains) losses 16,500,000  
Policy acquisition costs deferred (43,500,000)  
Policy acquisition cost amortization 68,300,000  
Interest credited 122,300,000  
Equity in earnings of limited partnerships and other investments (100,000)  
Change in:    
Accrued investment income (5,500,000)  
Deferred income taxes, net (5,700,000)  
Receivables 300,000  
Policy liabilities and accruals (171,300,000)  
Due to/from affiliate 10,900,000  
Other operating activities, net (14,200,000)  
Cash provided by (used for) operating activities (76,600,000)  
Purchases of:    
Available-for-sale debt securities (584,000,000)  
Derivative instruments (29,200,000)  
Fair value investments (2,900,000)  
Other investments 0  
Sales, repayments and maturities of:    
Proceeds from sales 286,800,000  
Derivative instruments 12,100,000  
Fair value investments 3,000,000  
Other investments 0  
Contributions to limited partnerships (900,000)  
Distributions from limited partnerships 200,000  
Policy loans, net 2,400,000  
Other investing activities, net (400,000)  
Cash provided by (used for) investing activities (312,900,000)  
FINANCING ACTIVITIES:    
Policyholder deposit fund deposits 540,500,000  
Policyholder deposit fund withdrawals (265,400,000)  
Net transfers to/from separate accounts 142,000,000  
Cash provided by (used for) financing activities 417,100,000  
Change in cash and cash equivalents 27,600,000  
Cash and cash equivalents, beginning of year 49,500,000 49,500,000
Cash and cash equivalents, end of year 77,100,000  
Supplemental Disclosure of Cash Flow Information    
Income taxes paid (refunded) 22,200,000  
Non-Cash Transactions During the Year    
Investment exchanges $ 14,000,000